In MS, aberrant TJ regulation, including altered expression and phosphorylation of claudin-5 and occludin, contributes to barrier dysfunction and facilitates immune cell infiltration, which drives neuroinflammation and disease progression [280]. This evidence concerns the gene OCLN and myeloid sarcoma.